5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 11.82▼ | 11.85▼ | 11.85▼ | 11.76▼ | 12.06▼ |
MA10 | 12.04▼ | 12.05▼ | 12.05▼ | 11.95▼ | 12.47▼ |
MA20 | 12.05▼ | 12.08▼ | 12.12▼ | 12.01▼ | 13.88▼ |
MA50 | 12.70▼ | 13.04▼ | 13.21▼ | 12.49▼ | 15.33▼ |
MA100 | 14.20▼ | 14.73▼ | 14.95▼ | 14.00▼ | 17.59▼ |
MA200 | 15.52▼ | 15.55▼ | 15.70▼ | 15.21▼ | 19.48▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.007▲ | 0.041▲ | 0.047▲ | -0.011▼ | -0.119▼ |
RSI | 35.381▼ | 34.905▼ | 34.481▼ | 39.688▼ | 33.768▼ |
STOCH | 3.843▼ | 19.911▼ | 22.388 | 20.099 | 15.083▼ |
WILL %R | -100.000▼ | -100.000▼ | -95.977▼ | -75.000 | -89.562▼ |
CCI | -111.889▼ | -141.919▼ | -95.816 | -94.674 | -104.127▼ |
▲ GAP | $EEV Open Gap Up %2 | Set Alert |
Monday, August 11, 2025 10:00 PM
Detailed price information for Ultrashort MSCI Emerging Markets -2X ETF (EEV-A) from The Globe and Mail including charting and trades.
|
Sunday, August 10, 2025 12:02 PM
Detailed price information for Entrada Therapeutics Inc (TRDA-Q) from The Globe and Mail including charting and trades.
|
Wednesday, August 06, 2025 06:26 AM
Collaboration Revenue: Collaboration revenue was $2.0 million for the second quarter of 2025, compared to $94.7 million for the same period in 2024. This decrease is primarily attributable to the ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 11.68 | 11.76 | 11.68 | 11.74 | 3,700 |
14/08/25 | 11.72 | 11.81 | 11.71 | 11.7748 | 25,062 |
13/08/25 | 11.45 | 11.51 | 11.43 | 11.49 | 11,900 |
12/08/25 | 11.94 | 11.94 | 11.75 | 11.76 | 17,700 |
11/08/25 | 11.95 | 12.06 | 11.95 | 12.05 | 5,300 |
08/08/25 | 12.02 | 12.02 | 12.00 | 12.01 | 6,500 |
07/08/25 | 11.88 | 11.98 | 11.88 | 11.9391 | 9,304 |
06/08/25 | 12.22 | 12.22 | 12.13 | 12.15 | 7,400 |
05/08/25 | 12.17 | 12.2205 | 12.17 | 12.2205 | 12,968 |
04/08/25 | 12.33 | 12.35 | 12.25 | 12.34 | 3,200 |
|
|
||||
|
|
||||
|
|